Want to know when you can expect your tax refund in 2025? We have our estimated IRS tax refund schedule right here, which we confirm has been pretty accurate for…
Investment
-
-
Investment
How to Get Higher Income Now That Cash Interest Rate is Falling? Find Dividend Income Funds?
I have a friend who pinged me regarding his financial situation. He feels that his current cash allocation of $580,000 is rather high and wonder if it is a good…
-
Here is an update of my investment portfolios for Feb 2025. My SGX Income Portfolio value decreases to $372k from $387k. S-Reits and property stocks remain feeble as Donald Trump’s…
-
February 28, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas issues market commentary from Quasar Elizundia, Expert Research Strategist at Pepperstone “The Chilean Peso remained…
-
Gold miner Ramelius Resources (ASX:RMS,OTC Pink:RMLRF) received the prestigious Craig Oliver Award at the RIU Explorers Conference in Fremantle, Western Australia, held from February 18 to 20. Established in 2011,…
-
Key Points The Department of Education has halted all income-driven repayment (IDR) plan applications, including online and paper submissions, following a court order. Borrowers who missed their IDR recertification deadline…
-
Our company is looking for insurance advisory specialists and also a sales support & service executive. Let me take some time to explain both roles so that you can see…
-
What Happened? Nvidia reported its fourth-quarter fiscal year 2025 results for the period ending 31 January 2025. Key highlights include: Record Growth in Revenue: Nvidia reported a record quarterly revenue…
-
February 26, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Enveric Biosciences (NASDAQ: ENVB),…
-
Investment
Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today announced that it has completed its trial entitled “A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple…